Discover
GSK
GSK plc
51.30
300 x undefined
700 x undefined
bid
ask
-
1.12
2.14%
500 @ 04:00 PM
52.21 +0.91 (1.77%)
| Ytd | 4.61% | |
| 1y | 31.71% |
51.08
day range
52.24
35.45
52 week range
61.70
| Open | 52.20 | Prev Close | 52.42 | Low | 51.08 | High | 52.24 | Mkt Cap | 102.74B |
| Vol | 3.01M | Avg Vol | 3.90M | EPS | 3.75 | P/E | 13.68 | Forward P/E | 10.23 |
| Beta | 0.29 | Short Ratio | 2.24 | Inst. Own | 18.86% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | 05-15 | Earning | 07-28 | 50-d Avg | 51.65 | 200-d Avg | 50.54 | 1yr Est | 56.63 |
| Income Statement | |||
| Total Revenue | 7.63B | ||
| Revenues (USD) | 10.17B | ||
| Cost of Revenue | 1.88B | ||
| Gross Profit | 5.75B | ||
| Operating Expenses | 3.46B | ||
| Research and Development Expense | 1.69B | ||
| Selling, General and Administrative Expense | 2.12B | ||
| Operating Income | 2.29B | ||
| Interest Expense | 167.00M | ||
| Income Tax Expense | 305.00M | ||
| Net Income | 1.74B | ||
| Net Income Common Stock | 1.74B | ||
| Net Income Common Stock (USD) | 2.32B | ||
| Consolidated Income | 1.84B | ||
| Net Income to Non-Controlling Interests | 102.00M | ||
| Earnings per Basic Share | 0.86 | ||
| Earnings per Basic Share (USD) | 1.15 | ||
| Earnings per Diluted Share | 0.85 | ||
| Dividends per Basic Common Share | 0.49 | ||
| Earning Before Interest & Taxes (EBIT) | 2.21B | ||
| Earning Before Interest & Taxes (USD) | 2.95B | ||
| Weighted Average Shares | 4.08B | ||
| Balance Sheet | |||
| Cash and Equivalents | 3.44B | ||
| Cash and Equivalents (USD) | 4.59B | ||
| Investments | 959.00M | ||
| Investments Current | 1000.00K | ||
| Investments Non-Current | 958.00M | ||
| Trade and Non-Trade Receivables | 7.76B | ||
| Current Assets | 17.76B | ||
| Property, Plant & Equipment Net | 10.04B | ||
| Total Assets | 62.87B | ||
| Debt Current | 5.04B | ||
| Total Debt | 19.06B | ||
| Current Liabilities | 22.43B | ||
| Debt Non-Current | 14.01B | ||
| Total Liabilities | 45.45B | ||
| Accumulated Retained Earnings (Deficit) | 11.59B | ||
| Shareholders Equity | 18.28B | ||
| Shareholders Equity (USD) | 24.38B | ||
| Assets Non-Current | 45.11B | ||
| Total Debt (USD) | 25.41B | ||
| Goodwill and Intangible Assets | 25.43B | ||
| Inventory | 6.16B | ||
| Liabilities Non-Current | 23.02B | ||
| Trade and Non-Trade Payables | 14.34B | ||
| Tax Assets | 6.49B | ||
| Tax Liabilities | 913.00M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 463.00M | ||
| Net Cash Flow from Financing | 272.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -53.00M | ||
| Capital Expenditure | -194.00M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -1.16B | ||
| Issuance (Purchase) of Equity Shares | -318.00M | ||
| Issuance (Repayment) of Debt Securities | 1.13B | ||
| Payment of Dividends & Other Cash Distributions | -643.00M | ||
| Net Cash Flow from Investing | -1.47B | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.00M | ||
| Net Cash Flow from Operations | 1.14B | ||
| Effect of Exchange Rate Changes on Cash | 2.00M | ||